$13.07
0.08% today
NYSE, Apr 02, 09:20 pm CET
ISIN
US69913P1057
Symbol
FNA
Sector

Paragon 28 Stock price

$13.06
+0.03 0.23% 1M
+6.71 105.67% 6M
+2.73 26.43% YTD
+1.01 8.38% 1Y
-5.19 28.44% 3Y
-5.65 30.20% 5Y
-5.65 30.20% 10Y
NYSE, Closing price Tue, Apr 01 2025
+0.00 0.00%
ISIN
US69913P1057
Symbol
FNA
Sector

Key metrics

Market capitalization $1.10b
Enterprise Value $1.17b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.58
P/S ratio (TTM) P/S ratio 4.28
P/B ratio (TTM) P/B ratio 8.39
Revenue growth (TTM) Revenue growth 18.39%
Revenue (TTM) Revenue $256.18m
EBIT (operating result TTM) EBIT $-40.78m
Free Cash Flow (TTM) Free Cash Flow $-42.96m
Cash position $34.58m
EPS (TTM) EPS $-0.66
P/E forward negative
P/S forward 3.76
EV/Sales forward 4.02
Short interest 2.58%
Show more

Is Paragon 28 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Paragon 28 Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Paragon 28 forecast:

4x Hold
100%

Analyst Opinions

4 Analysts have issued a Paragon 28 forecast:

Hold
100%

Financial data from Paragon 28

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
256 256
18% 18%
100%
- Direct Costs 83 83
23% 23%
32%
173 173
16% 16%
68%
- Selling and Administrative Expenses 168 168
13% 13%
66%
- Research and Development Expense 27 27
10% 10%
11%
-22 -22
26% 26%
-9%
- Depreciation and Amortization 19 19
19% 19%
7%
EBIT (Operating Income) EBIT -41 -41
11% 11%
-16%
Net Profit -55 -55
5% 5%
-21%

In millions USD.

Don't miss a Thing! We will send you all news about Paragon 28 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Paragon 28 Stock News

Neutral
Business Wire
about 3 hours ago
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer Biomet Holdings, Inc. (NYSE: ZBH). Under the terms of the proposed transaction, shareholders of Paragon will receive $13.00 in cash as well as a non-tradeable contingent valu...
Neutral
GlobeNewsWire
8 days ago
PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Paragon 28, Inc. (“Paragon”) (NYSE: FNA) shareholders.
Neutral
Business Wire
9 days ago
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference. From March 27-29, Paragon 28 will feature a suite of recently launched products designed to improve foot and...
More Paragon 28 News

Company Profile

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.

Head office United States
CEO Albert DaCosta
Employees 525
Founded 2010
Website www.paragon28.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today